MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Superior cluneal neuralgia in Parkinson’s disease: frequency and clinical features.

M. Mihara, Y. Kajiyama, A. Saito, R. Satake, Y. Kutoku (Kurashiki, Japan)

Meeting: 2025 International Congress

Keywords: Pain, Parkinsonism

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: We investigated the frequency and clinical characteristics of superior cluneal neuralgia (SCN) in patients with Parkinson’s disease (PD).

Background: The superior cluneal nerve is a cutaneous branch of the posterior root of the spinal nerve Th11-L4, and in recent years it has attracted attention as a cause of unexplained unilateral low back pain, with a reported frequency of 1.3-15% of low back pain cases. However, there are insufficient data on its incidence and clinical characteristics in PD.

Method: We evaluated the presence or absence of back pain and the presence or absence of symptoms characteristic of SCN damage in 92 consecutive PD patients who were outpatients at our hospital, in addition to evaluating their clinical symptoms. We also re-evaluated 61 patients after 1 year. At 1 year follow-up, patients with SCN still had higher UPDRS part 1 scores and there was a trend towards greater reduction in motor symptoms.

Results: The mean age of the patients was 70.2±11.3 years, the mean disease duration was 7.4±6.5 years, and the mean MDS-UPDRS part 3 score was 32.2±13.6. Fifty-two patients (56%) had back pain, and there were no differences in clinical symptoms, disease duration, etc. between patients with and without back pain. 

Of the 52 patients with back pain, 12 (23%) had SCN and their symptoms improved with nerve block. When comparing patients with and without SCN, patients with SCN had more severe pain (VAS 65.8±22.1 vs 37.5±21.7) and higher UPDRS part 1 scores (14.8±5.2 vs 10.5±5.0). 

At 1 year follow-up, patients with SCN still had higher UPDRS part 1 scores and there was a trend towards a greater decrease in motor symptoms.

Conclusion: SCN accounts for 25% of PD-related back pain and SCN may be associated with poorer quality of life due to more severe back pain and faster motor symptom decline. SCN is highly responsive to treatment and is an important consideration in clinical practice.

Table 1

Table 1

Table2

Table2

Figure

Figure

To cite this abstract in AMA style:

M. Mihara, Y. Kajiyama, A. Saito, R. Satake, Y. Kutoku. Superior cluneal neuralgia in Parkinson’s disease: frequency and clinical features. [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/superior-cluneal-neuralgia-in-parkinsons-disease-frequency-and-clinical-features/. Accessed October 22, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/superior-cluneal-neuralgia-in-parkinsons-disease-frequency-and-clinical-features/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley